Krieg T - Search Results

1

Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis.

Teruel M, Simeon CP, Broen J, Vonk MC, Carreira P, Camps MT, García-Portales R, Delgado-Frías E, Gallego M, Espinosa G; Spanish Scleroderma Group; Beretta L, Airó P, Lunardi C, Riemekasten G, Witte T, Krieg T, Kreuter A, Distler JH, Hunzelmann N, Koeleman BP, Voskuyl AE, Schuerwegh AJ, González-Gay MA, Radstake TR, Martin J. Teruel M, et al. Among authors: krieg t. Arthritis Res Ther. 2012 Jun 25;14(3):R154. doi: 10.1186/ar3890. Arthritis Res Ther. 2012. PMID: 22731751 Free PMC article.

2

[Current pathophysiological aspects of systemic sclerosis].

Krieg T, Hunzelmann N. Krieg T, et al. Z Rheumatol. 2006 Jul;65(4):275-8. doi: 10.1007/s00393-006-0066-z. Z Rheumatol. 2006. PMID: 16807741 Review. German.

3

Association of killer cell immunoglobulin-like receptors with scleroderma.

Momot T, Koch S, Hunzelmann N, Krieg T, Ulbricht K, Schmidt RE, Witte T. Momot T, et al. Among authors: krieg t. Arthritis Rheum. 2004 May;50(5):1561-5. doi: 10.1002/art.20216. Arthritis Rheum. 2004. PMID: 15146426 Free article.

4

Scleroderma: from pathophysiology to novel therapeutic approaches.

Hunzelmann N, Krieg T. Hunzelmann N, et al. Among authors: krieg t. Exp Dermatol. 2010 May;19(5):393-400. doi: 10.1111/j.1600-0625.2010.01082.x. Exp Dermatol. 2010. PMID: 20507361 Review.

5

High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy.

Hunzelmann N, Moinzadeh P, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Müller-Ladner U, Olski TM, Pfeiffer C, Riemekasten G, Schulze-Lohoff E, Sunderkoetter C, Weber M; German Network for Systemic Scleroderma Centers. Hunzelmann N, et al. Among authors: krieg t. Arthritis Res Ther. 2009;11(2):R30. doi: 10.1186/ar2634. Epub 2009 Mar 4. Arthritis Res Ther. 2009. PMID: 19261182 Free PMC article.

6

Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.

Schwinzer R, Witte T, Hundrieser J, Ehlers S, Momot T, Hunzelmann N, Krieg T, Schmidt RE, Wonigeit K. Schwinzer R, et al. Among authors: krieg t. Genes Immun. 2003 Mar;4(2):168-9. doi: 10.1038/sj.gene.6363894. Genes Immun. 2003. PMID: 12618866

7

Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement.

Moinzadeh P, Krieg T, Hellmich M, Brinckmann J, Neumann E, Müller-Ladner U, Kreuter A, Dumitrescu D, Rosenkranz S, Hunzelmann N. Moinzadeh P, et al. Among authors: krieg t. Exp Dermatol. 2011 Sep;20(9):770-3. doi: 10.1111/j.1600-0625.2011.01321.x. Epub 2011 Jun 26. Exp Dermatol. 2011. PMID: 21707759

8

[The German network for systemic sclerosis (DNSS): current data on diagnostics and therapy].

Hunzelmann N, Krieg T; Kooperationspartner der DNSS. Hunzelmann N, et al. Among authors: krieg t. Hautarzt. 2012 Apr;63 Suppl 1:71-5. doi: 10.1007/s00105-011-2300-0. Hautarzt. 2012. PMID: 22543950 Review. German.

9

Overview of pathogenesis of systemic sclerosis.

Abraham DJ, Krieg T, Distler J, Distler O. Abraham DJ, et al. Among authors: krieg t. Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii3-7. doi: 10.1093/rheumatology/ken481. Rheumatology (Oxford). 2009. PMID: 19487220 Free article. Review.

10

Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis.

Moinzadeh P, Hunzelmann N, Krieg T. Moinzadeh P, et al. Among authors: krieg t. J Am Acad Dermatol. 2011 Sep;65(3):e102-e104. doi: 10.1016/j.jaad.2011.04.029. J Am Acad Dermatol. 2011. PMID: 21839301 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

664 results

Search Page